Sanofi SA (EPA: SAN)‘s stock had its “outperform” rating reaffirmed by research analysts at Sanford C. Bernstein in a report released on Friday. They currently have a $98.72 (€77) target price on the stock.

Shares of Sanofi SA traded up 1.36% during mid-day trading on Friday, hitting €68.59. Sanofi SA has a 52 week low of €47.00 and a 52 week high of €69.95. The company has a market cap of €90.385 billion and a P/E ratio of 14.98.

Several other analysts have also recently commented on the stock. Analysts at AlphaValue reiterated an “add” rating on shares of Sanofi SA in a research note to investors on Thursday. They now have a $97.56 price target on the stock. Separately, analysts at Societe Generale reiterated a “buy” rating on shares of Sanofi SA in a research note to investors on Wednesday. They now have a $108.97 price target on the stock. Finally, analysts at Credit Suisse reiterated a “neutral” rating on shares of Sanofi SA in a research note to investors on Monday. They now have a $92.31 price target on the stock.

Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.